A prostate cancer diagnosis rarely comes with one obvious answer. It comes with several reasonable paths that differ in side effects, recovery and long term tradeoffs, and the right one depends on the ...
Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...
Choosing prostate cancer treatment takes more than explaining options. Explore strategies to communicate risks, clarify ...
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...
In an interview, Dr. David A. Taub highlighted Prostate Cancer Awareness Month by outlining current treatment options for patients with prostate cancer. In an interview with CURE, Dr. David A. Taub ...
A new clinical guideline from the American Society for Radiation Oncology (ASTRO) recommends shorter courses of radiation ...
In the first-in-human TheraPb phase 1 trial, the alpha-emitting radiopharmaceutical 212Pb-ADVC001 was well tolerated at doses ...
Mercy Medical Center was expanding advanced treatment options for men with prostate cancer through the enhanced capabilities of its Varian TrueBeam radiotherapy system, providing appropriately ...
(n=6) remain disease-free more than two years after treatment; 80% of patients treated with SYNC-T Therapy SV-102 (n=15) alive at ...
Newswise — (Baltimore, Maryland -Oct. 13th, 2026)-- Mercy Medical Center is expanding advanced treatment options for men with prostate cancer through the enhanced capabilities of its Varian TrueBeam ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results